Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · IEX Real-Time Price · USD
1.420
+0.020 (1.43%)
Jul 22, 2024, 10:12 AM EDT - Market open
Spero Therapeutics Employees
Spero Therapeutics had 46 employees as of December 31, 2023. The number of employees increased by 11 or 31.43% compared to the previous year.
Employees
46
Change (1Y)
11
Growth (1Y)
31.43%
Revenue / Employee
$2,412,565
Profits / Employee
$508,761
Market Cap
76.09M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
SHL Telemedicine | 583 |
MDxHealth | 300 |
Eagle Pharmaceuticals | 134 |
T2 Biosystems | 113 |
Kronos Bio | 63 |
Ovid Therapeutics | 40 |
enVVeno Medical | 31 |
Cognition Therapeutics | 28 |
SPRO News
- 18 days ago - Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Spero Therapeutics to Participate in H.C. Wainwright Annual BioConnect Investor Conference - GlobeNewsWire
- 2 months ago - Spero Therapeutics Announces First Quarter 2024 Operating Results and Provides a Business Update - GlobeNewsWire
- 2 months ago - Spero Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on Wednesday, May 15, 2024 - GlobeNewsWire
- 2 months ago - Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 months ago - Spero Therapeutics Announces Fourth Quarter and Full Year 2023 Operating Results and Provides a Business Update - GlobeNewsWire
- 4 months ago - Spero Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 13, 2024 - GlobeNewsWire
- 5 months ago - Spero Therapeutics Announces Clearance of IND for SPR206 to Treat MDR Gram-negative Bacterial Infections - GlobeNewsWire